RKVTF
Rakovina Therapeutics Inc

63
Mkt Cap
$2.03M
Volume
10,000.00
52W High
$0.6658
52W Low
$0.0404
PE Ratio
-0.26
RKVTF Fundamentals
Price
$0.096
Prev Close
$0.0785
Open
$0.096
50D MA
$0.0815
Beta
0.00
Avg. Volume
843.00
EPS (Annual)
-$0.3433
P/B
19.92
Loading...
Loading...

About

Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded on May 6, 2019 and is headquartered in Vancouver, Canada.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Rakovina Therapeutics Inc?
What is the 52-week high for Rakovina Therapeutics Inc?
What is the 52-week low for Rakovina Therapeutics Inc?
What is Rakovina Therapeutics Inc stock price today?
What was Rakovina Therapeutics Inc stock price yesterday?
What is the PE ratio of Rakovina Therapeutics Inc?
What is the Price-to-Book ratio of Rakovina Therapeutics Inc?
What is the 50-day moving average of Rakovina Therapeutics Inc?

Latest RKVTF News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.